Quantum BioPharma Ltd. Proceeds From Exercise Of Warrants
Quantum BioPharma Ltd. (QNTM) reported Proceeds From Exercise Of Warrants of $43.26 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2026-03-26
- Quantum BioPharma Ltd. proceeds from exercise of warrants for the quarter ending 2025-12-31 was $0.00.
- Quantum BioPharma Ltd. proceeds from exercise of warrants for the quarter ending 2025-09-30 was $0.00.
- Quantum BioPharma Ltd. proceeds from exercise of warrants for the quarter ending 2024-12-31 was $0.00.
- Quantum BioPharma Ltd. proceeds from exercise of warrants for the quarter ending 2024-09-30 was $0.00.
| Period end | Proceeds From Exercise Of Warrants 3 month | Proceeds From Exercise Of Warrants 6 month | Proceeds From Exercise Of Warrants 9 month | Proceeds From Exercise Of Warrants 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $43.26K 20-F · filed 2026-03-26 | |
| 2025-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $43.26K 6-K · filed 2025-11-06 | ||
| 2025-06-30 | $43.26K 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 20-F · filed 2026-03-26 | |
| 2024-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $0.00 6-K · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $0.00 20-F · filed 2026-03-26 | |||
| 2021-12-31 | $0.00 20-F · filed 2022-03-31 | |||
| 2020-12-31 | $0.00 20-F · filed 2022-03-31 | |||
| 2019-12-31 | $71.46K 20-F · filed 2022-03-31 |